Validation of GWAS-Identified CDKN2A Variant rs10757278 in Cardiomyopathy Patients of Pakistani Cohort
Authors:
- Muhammad Noor Ul AminMAMuhammad Noor Ul Amin
- Umm e HabibaUHUmm e Habiba
- Shahid RashidSRShahid Rashid
- Asad Mehmood RajaARAsad Mehmood Raja
- Muhammad IlyasMIMuhammad Ilyas
- Rafaqat IshaqRIRafaqat Ishaq
- Abida ArshadAAAbida Arshad
- Muhamamd Javaid AsadMAMuhamamd Javaid Asad
- Ghazala Kaukab RajaGRGhazala Kaukab Raja
- Pakeeza Arzoo ShaiqPSPakeeza Arzoo Shaiq
Preprint
- 21 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Cardiomyopathies, a leading cause of heart failure and mortality worldwide, are a diverse group of heart muscle disorders, with dilated cardiomyopathy being the most prevalent subtype. Numerous genetic variants, identified through GWAS and candidate gene studies, are associated with cardiomyopathies. This study aimed to evaluate the association of the rs10757278 SNP polymorphism on chromosome 9p21.3 near the CDKN2A and CDKN2B genes with cardiomyopathy, focusing on its role in genetic susceptibility to ischemic dilated cardiomyopathy. Methods: A case-control study was conducted with 200 participants (100 cardiomyopathy patients and 100 controls). Clinical and echocardiographic parameters were recorded, and genotyping was performed using tetra-arms PCR. Results: Statistical analysis revealed that rs10757278 was significantly associated with cardiomyopathy (Chi-sq=11.679, p=0.00291) in allelic and genotypic distributions. The GG genotype (p=0.00958) increased risk, identifying the G allele as the risk allele. For IDCM, significant associations were observed for GG and AG genotypes (p=0.02613, p=0.00104), with the G allele increasing risk (p=0.0031, OR=3.19, CI=1.51–7.17) and the A allele offering protection (p=0.00961, OR=0.35, CI=0.15–0.177). Conclusion: These findings highlight rs10757278 as a potential biomarker for cardiomyopathy risk profiling. Further large-scale studies are warranted to confirm these results and improve early diagnosis and genetic risk prediction for cardiomyopathies.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Treatment of heart failure using angiotensin receptor neprilysin inhibitor2024
- What Causes Premature Coronary Artery Disease?Current Atherosclerosis Reports, 2024
- Associations between low serum levels of ANRIL and some common gene SNPs in Iranian patients with premature coronary artery diseaseScientific Reports, 2024
- Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic optionsHeart Failure Reviews, 2023
- Large-scale genome-wide association study of coronary artery disease in genetically diverse populationsNature Medicine, 2022
- Impact of 9p21.3 region and atherosclerosis-related genes' variants on long-term recurrent hard cardiac events after a myocardial infarctionGene, 2018
- Genetic characterization of northeastern Italian population isolates in the context of broader European genetic diversityEuropean Journal of Human Genetics, 2012
- The rs10757278 Polymorphism of the 9p21.3 Locus Is Associated with Premature Coronary Artery Disease in Polish PatientsGenetic Testing and Molecular Biomarkers, 2012
- Variant on 9p21 Is Strongly Associated with Coronary Artery Disease but Lacks Association with Myocardial Infarction and Disease Severity in a Population in Western IndiaArchives of Medical Research, 2011
- Kardiomyopathien und Myokardbiopsie im Spiegel der neuen KlassifikationenHerz, 2009